The vaccine, Pfizer’s Abrysvo, is a bivalent shot approved to prevent lower respiratory tract disease caused by RSV, according to a news release from the drugmaker.
GSK received the first approval for an RSV shot May 3 with its Arexvy vaccine.
There are no approved RSV vaccines for children, another population vulnerable to the virus.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
